Clinical trial
Examining Patient Attributes To Determine Optimal Treatment Outcome in Irritable Bowel Syndrome.
NCT01297556 is registered in ClinicalTrials.gov with Michigan Gastroenterology Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Examining Patient Attributes To Determine Optimal Treatment Outcome in Irritable Bowel Syndrome.
- Lead sponsor
- Michigan Gastroenterology Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2011
- Completion date
- December 31, 2011
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.